Involvement of the nucleus accumbens shell glutamatergic system in ACPA-induced impairment of inhibitory avoidance memory consolidation

Behavioural Brain Research

Volumn 269, Issue , 2014, Pages 28-36

  Rasekhi, Khalil ^a   Oryan, Shahrbanoo ^a   Nasehi, Mohammad ^b   Zarrindast, Mohammad Reza ^c,d,e,f  

^a KHARAZMI UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^f INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

Author keywords

ACPA; Inhibitory avoidance; NMDA; Nucleus accumbens shell; Rat

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 AMINO 7 PHOSPHONOHEPTANOIC ACID; ARACHIDONYL CYCLOPROPYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; 2 AMINO 5 PHOSPHONOVALERIC ACID; 2-AMINO-7-PHOSPHONOHEPTANOIC ACID; AMINO ACID RECEPTOR STIMULATING AGENT; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYLCYCLOPROPYLAMIDE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; N METHYLASPARTIC ACID; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; GLUTAMATERGIC SYSTEM; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MENTAL TASK; NONHUMAN; NUCLEUS ACCUMBENS; PASSIVE AVOIDANCE; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TASK PERFORMANCE; TREATMENT OUTCOME; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; MEMORY; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; ARACHIDONIC ACIDS; AVOIDANCE LEARNING; CANNABINOID RECEPTOR AGONISTS; CANNABINOID RECEPTOR ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; MALE; MEMORY; MEMORY DISORDERS; MOTOR ACTIVITY; N-METHYLASPARTATE; NUCLEUS ACCUMBENS; PIPERIDINES; PYRAZOLES; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

EID: 84899889360     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.04.006     Document Type: Article

References (115)

1. Cardinal R.N., Parkinson J.A., Hall J., Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 2002, 26:321-352.
2. Groenewegen H.J., Trimble M. The ventral striatum as an interface between the limbic and motor systems. CNS Spectr 2007, 12:887-892.
3. Setlow B. The nucleus accumbens and learning and memory. J Neurosci Res 1997, 49:515-521.
4. Ikemoto S., Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 1999, 31:6-41.
5. Sesack S.R., Grace A.A. Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 2010, 35:27-47.
6. Carlezon W.A., Thomas M.J. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 2009, 56(Suppl 1):122-132.
7. Delgado M.R., Li J., Schiller D., Phelps E.A. The role of the striatum in aversive learning and aversive prediction errors. Philos Trans R Soc London, Ser B: Biol Sci 2008, 363:3787-3800.
8. Kerfoot E.C., Agarwal I., Lee H.J., Holland P.C. Control of appetitive and aversive taste-reactivity responses by an auditory conditioned stimulus in a devaluation task: a FOS and behavioral analysis. Learn Mem 2007, 14:581-589.
9. LaLumiere R.T., Nawar E.M., McGaugh J.L. Modulation of memory consolidation by the basolateral amygdala or nucleus accumbens shell requires concurrent dopamine receptor activation in both brain regions. Learn Mem 2005, 12:296-301.
10. Li M., Parkes J., Fletcher P.J., Kapur S. Evaluation of the motor initiation hypothesis of APD-induced conditioned avoidance decreases. Pharmacol Biochem Behav 2004, 78:811-819.
11. McCullough L.D., Sokolowski J.D., Salamone J.D. A neurochemical and behavioral investigation of the involvement of nucleus accumbens dopamine in instrumental avoidance. Neuroscience 1993, 52:919-925.
12. Salamone J.D., Correa M., Farrar A., Mingote S.M. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl) 2007, 191:461-482.
13. Salamone J.D., Cousins M.S., Snyder B.J. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 1997, 21:341-359.
14. Ventura R., Morrone C., Puglisi-Allegra S. Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Proc Nat Acad Sci USA 2007, 104:5181-5186.
15. Finch D.M. Neurophysiology of converging synaptic inputs from the rat prefrontal cortex, amygdala, midline thalamus, and hippocampal formation onto single neurons of the caudate/putamen and nucleus accumbens. Hippocampus 1996, 6:495-512.
16. Groenewegen H.J., Wright C.I., Beijer A.V., Voorn P. Convergence and segregation of ventral striatal inputs and outputs. Ann NY Acad Sci 1999, 877:49-63.
17. McDonald A.J. Organization of amygdaloid projections to the prefrontal cortex and associated striatum in the rat. Neuroscience 1991, 44:1-14.
18. Meredith G.E., Wouterlood F.G., Pattiselanno A. Hippocampal fibers make synaptic contacts with glutamate decarboxylase-immunoreactive neurons in the rat nucleus accumbens. Brain Res 1990, 513:329-334.
19. O'Donnell P., Grace A.A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci 1995, 15:3622-3639.
20. Petrovich G.D., Risold P.Y., Swanson L.W. Organization of projections from the basomedial nucleus of the amygdala: a PHAL study in the rat. J Comp Neurol 1996, 374:387-420.
21. Reynolds S.M., Berridge K.C. Positive and negative motivation in nucleus accumbens shell: bivalent rostrocaudal gradients for GABA-elicited eating, taste "liking"/"disliking" reactions, place preference/avoidance, and fear. J Neurosci 2002, 22:7308-7320.
22. Roozendaal B., de Quervain D.J., Ferry B., Setlow B., McGaugh J.L. Basolateral amygdala-nucleus accumbens interactions in mediating glucocorticoid enhancement of memory consolidation. J Neurosci 2001, 21:2518-2525.
23. Horne A.L., Woodruff G.N., Kemp J.A. Synaptic potentials mediated by excitatory amino acid receptors in the nucleus accumbens of the rat, in vitro. Neuropharmacology 1990, 29:917-921.
24. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
25. Goosens K.A., Maren S. Long-term potentiation as a substrate for memory: evidence from studies of amygdaloid plasticity and Pavlovian fear conditioning. Hippocampus 2002, 12:592-599.
26. Goto Y., Grace A.A. Limbic and cortical information processing in the nucleus accumbens. Trends Neurosci 2008, 31:552-558.
27. McGaugh J.L. Memory-a century of consolidation. Science 2000, 287:248-251.
28. Le Jeune H., Cecyre D., Rowe W., Meaney M.J., Quirion R. Ionotropic glutamate receptor subtypes in the aged memory-impaired and unimpaired Long-Evans rat. Neuroscience 1996, 74:349-363.
29. Malenka R.C., Bear M.F.L.T.P LTD: an embarrassment of riches. Neuron 2004, 44:5-21.
30. Gerdeman G.L., Lovinger D.M. Emerging roles for endocannabinoids in long-term synaptic plasticity. Br J Pharmacol 2003, 140:781-789.
31. Lichtman A.H., Varvel S.A., Martin B.R. Endocannabinoids in cognition and dependence. Prostaglandins Leukot Essent Fatty Acids 2002, 66:269-285.
32. Nasehi M., Piri M., Jamali-Raeufy N., Zarrindast M.R. Influence of intracerebral administration of NO agents in dorsal hippocampus (CA1) on cannabinoid state-dependent memory in the step-down passive avoidance test. Physiol Behav 2010, 100:297-304.
33. Pacher P., Batkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006, 58:389-462.
34. Zanettini C., Panlilio L.V., Alicki M., Goldberg S.R., Haller J., Yasar S. Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci 2011, 5:57.
35. Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 1999, 58:315-348.
36. Breivogel C.S., Childers S.R. The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis 1998, 5:417-431.
37. Herkenham M. Cannabinoid receptor localization in brain: relationship to motor and reward systems. Ann NY Acad Sci 1992, 654:19-32.
38. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol 2005, 29:9-325.
39. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
40. Pickel V.M., Chan J., Kash T.L., Rodriguez J.J., MacKie K. Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 2004, 127:101-112.
41. Begg M., Pacher P., Batkai S., Osei-Hyiaman D., Offertaler L., Mo F.M., et al. Evidence for novel cannabinoid receptors. Pharmacol Ther 2005, 106:133-145.
42. Brown A.J. Novel cannabinoid receptors. Br J Pharmacol 2007, 152:567-575.
43. Jamali-Raeufy N., Nasehi M., Zarrindast M.R. Influence of N-methyl D-aspartate receptor mechanism on WIN55,212-2-induced amnesia in rat dorsal hippocampus. Behav Pharmacol 2011, 22:645-654.
44. Sjostrom P.J., Turrigiano G.G., Nelson S.B. Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron 2003, 39:641-654.
45. De Leonibus E., Costantini V.J., Castellano C., Ferretti V., Oliverio A., Mele A. Distinct roles of the different ionotropic glutamate receptors within the nucleus accumbens in passive-avoidance learning and memory in mice. Eur J Neurosci 2003, 18:2365-2373.
46. Robbe D., Alonso G., Duchamp F., Bockaert J., Manzoni O.J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci 2001, 21:109-116.
47. Dudai Y. The neurobiology of consolidations, or, how stable is the engram. Annu Rev Psychol 2004, 55:51-86.
48. Izquierdo I. Different forms of post-training memory processing. Behav Neural Biol 1989, 51:171-202.
49. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, London, UK. 6rd ed.
50. Zarrindast M.R., Piri M., Nasehi M., Ebrahimi-Ghiri M. Nitric oxide in the nucleus accumbens is involved in retrieval of inhibitory avoidance memory by nicotine. Pharmacol Biochem Behav 2012, 101:166-173.
51. Gold P.E. The use of avoidance training in studies of modulation of memory storage. Behav Neural Biol 1986, 46:87-98.
52. Nasehi M., Sahebgharani M., Haeri-Rohani A., Zarrindast M.R. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiol Learn Mem 2009, 92:391-399.
53. Jamali-Raeufy N., Nasehi M., Ebrahimi-Ghiri M., Zarrindast M.R. Cross state-dependency of learning between WIN55, 212-2 and scopolamine in rat dorsal hippocampus. Neurosci Lett 2011, 491:227-231.
54. Khakpai F., Nasehi M., Haeri-Rohani A., Eidi A., Zarrindast M.R. Scopolamine induced memory impairment; possible involvement of NMDA receptor mechanisms of dorsal hippocampus and/or septum. Behav Brain Res 2012, 231:1-10.
55. Yousefi B., Nasehi M., Khakpai F., Zarrindast M.R. Possible interaction of cholinergic and GABAergic systems between MS and CA1 upon memory acquisition in rats. Behav Brain Res 2012, 235:231-243.
56. Ahmadi H., Nasehi M., Rostami P., Zarrindast M.R. Involvement of the nucleus accumbens shell dopaminergic system in prelimbic NMDA-induced anxiolytic-like behaviors. Neuropharmacology 2013, 71:112-123.
57. Chegini H.R., Nasehi M., Zarrindast M.R. Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice. Behav Brain Res 2014, 261:114-126.
58. Rezayof A., Sardari M., Zarrindast M.R., Nayer-Nouri T. Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference. Behav Brain Res 2011, 220:1-8.
59. Clarke J.R., Rossato J.I., Monteiro S., Bevilaqua L.R., Izquierdo I., Cammarota M. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory. Neurobiol Learn Mem 2008, 90:374-381.
60. Ghiasvand M., Rezayof A., Zarrindast M.R., Ahmadi S. Activation of cannabinoid CB1 receptors in the central amygdala impairs inhibitory avoidance memory consolidation via NMDA receptors. Neurobiol Learn Mem 2011, 96:333-338.
61. Heyser C.J., Hampson R.E., Deadwyler S.A. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J Pharmacol Exp Ther 1993, 264:294-307.
62. Nakamura E.M., da Silva E.A., Concilio G.V., Wilkinson D.A., Masur J. Reversible effects of acute and long-term administration of delta-9-tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Depend 1991, 28:167-175.
63. Pedroza-Llinas R., Mendez-Diaz M., Ruiz-Contreras A.E. Prospero-Garcia O. CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning. Behav Brain Res 2013, 237:141-147.
64. Robinson L., Goonawardena A.V., Pertwee R.G., Hampson R.E., Riedel G. The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats. Br J Pharmacol 2007, 151:688-700.
65. Azad S.C., Eder M., Marsicano G., Lutz B., Zieglgansberger W., Rammes G. Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn Mem 2003, 10:116-128.
66. Chevaleyre V., Takahashi K.A., Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 2006, 29:37-76.
67. Domenici M.R., Azad S.C., Marsicano G., Schierloh A., Wotjak C.T., Dodt H.U., et al. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci 2006, 26:5794-5799.
68. Hoffman A.F., Lupica C.R. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 2000, 20:2470-2479.
69. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 2009, 89:309-380.
70. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 2001, 22:565-572.
71. Hoffman A.F., Lupica C.R. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysiol 2001, 85:72-83.
72. Hoffman A.F., Oz M., Caulder T., Lupica C.R. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J Neurosci 2003, 23:4815-4820.
73. Robbe D., Kopf M., Remaury A., Bockaert J., Manzoni O.J. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Nat Acad Sci USA 2002, 99:8384-8388.
74. Da S., Takahashi R.N. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:321-325.
75. Mallet P.E., Beninger R.J. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology (Berl) 1998, 140:11-19.
76. Reich C.G., Mohammadi M.H., Alger B.E. Endocannabinoid modulation of fear responses: learning and state-dependent performance effects. J Psychopharmacol 2008, 22:769-777.
77. Suzuki A., Josselyn S.A., Frankland P.W., Masushige S., Silva A.J., Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 2004, 24:4787-4795.
78. Nazari-Serenjeh F., Rezayof A. Cooperative interaction between the basolateral amygdala and ventral tegmental area modulates the consolidation of inhibitory avoidance memory. Prog Neuropsychopharmacol Biol Psychiatry 2013, 40:54-61.
79. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5. Nature 1986, 319:774-776.
80. Rubin M.A., Stiegemeier J.A., Volkweis M.A., Oliveira D.M., Fenili A.C., Boemo R.L., et al. Intra-amygdala spermidine administration improves inhibitory avoidance performance in rats. Eur J Pharmacol 2001, 423:35-39.
81. de Lima M.N., Laranja D.C., Bromberg E., Roesler R., Schroder N. Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats. Behav Brain Res 2005, 156:139-143.
82. Quartermain D., Mower J., Rafferty M.F., Herting R.L., Lanthorn T.H. Acute but not chronic activation of the NMDA-coupled glycine receptor with d-cycloserine facilitates learning and retention. Eur J Pharmacol 1994, 257:7-12.
83. Villarreal D.M., Do V., Haddad E., Derrick B.E. NMDA receptor antagonists sustain LTP and spatial memory: active processes mediate LTP decay. Nat Neurosci 2002, 5:48-52.
84. Haul S., Godecke A., Schrader J., Haas H.L., Luhmann H.J. Impairment of neocortical long-term potentiation in mice deficient of endothelial nitric oxide synthase. J Neurophysiol 1999, 81:494-497.
85. Hensch T.K., Gordon J.A., Brandon E.P., McKnight G.S., Idzerda R.L., Stryker M.P. Comparison of plasticity in vivo and in vitro in the developing visual cortex of normal and protein kinase A RIbeta-deficient mice. J Neurosci 1998, 18:2108-2117.
86. Piochon C., Levenes C., Ohtsuki G., Hansel C. Purkinje cell NMDA receptors assume a key role in synaptic gain control in the mature cerebellum. J Neurosci 2010, 30:15330-15335.
87. Cakil D., Yildirim M., Ayyildiz M., Agar E. The effect of co-administration of the NMDA blocker with agonist and antagonist of CB1-receptor on penicillin-induced epileptiform activity in rats. Epilepsy Res 2011, 93:128-137.
88. Hampson R.E., Miller F., Palchik G., Deadwyler S.A. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Neuropharmacology 2011, 60:944-952.
89. Liu Q., Bhat M., Bowen W.D., Cheng J. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-d-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons. J Pharmacol Exp Ther 2009, 331:1062-1070.
90. Netzeband J.G., Conroy S.M., Parsons K.L., Gruol D.L. Cannabinoids enhance NMDA-elicited Ca2+ signals in cerebellar granule neurons in culture. J Neurosci 1999, 19:8765-8777.
91. Ohno-Shosaku T., Hashimotodani Y., Ano M., Takeda S., Tsubokawa H., Kano M. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons. J Physiol 2007, 584:407-418.
92. Rodriguez-Moreno A., Banerjee A., Paulsen O. Presynaptic NMDA Receptors and Spike Timing-Dependent Depression at Cortical Synapses. Front Synaptic Neurosci 2010, 2:18.
93. Verhoog M.B., Mansvelder H.D. Presynaptic ionotropic receptors controlling and modulating the rules for spike timing-dependent plasticity. Neural Plast 2011, 2011:870763.
94. Cormier R.J., Greenwood A.C., Connor J.A. Bidirectional synaptic plasticity correlated with the magnitude of dendritic calcium transients above a threshold. J Neurophysiol 2001, 85:399-406.
95. Franks K.M., Sejnowski T.J. Complexity of calcium signaling in synaptic spines. Bioessays 2002, 24:1130-1144.
96. Yang S.N., Tang Y.G., Zucker R.S. Selective induction of LTP and LTD by postsynaptic [Ca2+]i elevation. J Neurophysiol 1999, 81:781-787.
97. Maffei A. The many forms and functions of long term plasticity at GABAergic synapses. Neural Plast 2011, 2011:254724.
98. Robbe D., Alonso G., Manzoni O.J. Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens. Ann NY Acad Sci. 2003, 1003:212-225.
99. Zorumski C.F., Izumi Y. NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders. Neurosci Biobehav Rev 2012, 36:989-1000.
100. Cadogan A.K., Alexander S.P., Boyd E.A., Kendall D.A. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J Neurochem 1997, 69:1131-1137.
101. Calabresi P., Centonze D., Gubellini P., Pisani A., Bernardi G. Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation. Eur J Neurosci 1998, 10:2887-2895.
102. Carvalho A.F., Mackie K., Van Bockstaele E.J. Cannabinoid modulation of limbic forebrain noradrenergic circuitry. Eur J Neurosci 2010, 31:286-301.
103. Ceglia I., Carli M., Baviera M., Renoldi G., Calcagno E., Invernizzi R.W. The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC. J Neurochem 2004, 91:189-199.
104. Cepeda C., Levine M.S. Dopamine and N-methyl-d-aspartate receptor interactions in the neostriatum. Dev Neurosci 1998, 20:1-18.
105. Nakazi M., Bauer U., Nickel T., Kathmann M., Schlicker E. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol 2000, 361:19-24.
106. Narushima M., Uchigashima M., Fukaya M., Matsui M., Manabe T., Hashimoto K., et al. Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum. J Neurosci 2007, 27:496-506.
107. Manzoni O.J., Bockaert J. Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens. Eur J Pharmacol 2001, 412:R3-R5.
108. Pistis M., Muntoni A.L., Pillolla G., Gessa G.L. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. Eur J Neurosci 2002, 15:1795-1802.
109. Ahmadi S., Zarrindast M.R., Haeri-Rohani A., Rezayof A., Nouri M. Nicotine improves morphine-induced impairment of memory: possible involvement of N-methyl-d-aspartate receptors in the nucleus accumbens. Dev Neurobiol 2007, 67:1118-1127.
110. Lisman J.E., Grace A.A. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 2005, 46:703-713.
111. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 1995, 15:6552-6561.
112. Schweitzer P. Cannabinoids decrease the K(+) M-current in hippocampal CA1 neurons. J Neurosci 2000, 20:51-58.
113. Breivogel C.S., Griffin G., Di Marzo V., Martin B.R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 2001, 60:155-163.
114. Hajos N., Ledent C., Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 2001, 106:1-4.
115. Pistis M., Perra S., Pillolla G., Melis M., Gessa G.L., Muntoni A.L. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 2004, 46:115-125.